Serum neopterin in acute coronary syndromes

Slides:



Advertisements
Similar presentations
How do emotion and motivation direct executive control? Luiz Pessoa Trends in Cognitive Sciences Volume 13, Issue 4, Pages (April 2009) DOI: /j.tics
Advertisements

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study  Dr Jack R W Brownrigg,
The Epidemic of the 20th Century: Coronary Heart Disease
Volume 78, Issue 3, Pages (September 2008)
Pharmacogenetics and future drug development and delivery
Volume 385, Issue 9985, Pages (June 2015)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Individual gene expression and personalised medicine in sepsis
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
Mental illness and mental health
Frailty assessment in elderly people
Long-term effects of hormone replacement therapy
A twin with Cushing's disease
Wandering Acute Myocardial Infarction
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Do air quality alerts benefit public health? New evidence from Canada
Increased body-mass index in patients with narcolepsy
The Epidemic of the 20th Century: Coronary Heart Disease
Unreliable immunoassays, patients' safety, and clinical research
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Theo Nicholaou, Rachel Wong, Ian D Davis  The Lancet 
ECASS-II: intravenous alteplase in acute ischaemic stroke
T-DM1-related carotenoderma and hand-foot syndrome
What does STOP-2 tell us about management of hypertension?
SNPs and coronary heart disease – Authors' reply
Statins for prevention of stroke
Organisation of the care of patients with heart failure
Disease and stigma The Lancet Volume 354, (December 1999)
Meta-analysis of randomised controlled trials
Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz 
HIV myths should not be resuscitated
DEPARTMENT OF ERROR The Lancet Volume 362, Issue 9385, (August 2003)
Low-level lead exposure and mortality in US adults: a population-based cohort study  Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,
Effect of development assistance on domestic health expenditures
Sherif M Abdalla, Robert Bortolussi, Noni E MacDonald 
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome  Yongguang Lu, Lang Li, Hua Yan, Qiang.
Volume 375, Issue 9725, Pages (May 2010)
MRC/BHF Heart Protection Study
Volume 385, Issue 9985, Pages (June 2015)
Confessions of a journal junkie
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Volume 371, Issue 9627, Pages (May 2008)
Telling it like it isn't: truth and lies in a post-9/11 world
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Thank God for Richard Dawkins?
Low-technology approaches
The complexity of ABO in coronary heart disease
Do generic correction algorithms produce reliable estimates?
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Volume 373, Issue 9672, Pages (April 2009)
Volume 383, Issue 9921, Pages (March 2014)
Intracerebral haemorrhage during alemtuzumab administration
Spatial lifecourse epidemiology
Acute coronary syndromes: diagnosis
Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.
Cholesterol and all-cause mortality in Honolulu
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Volume 1, Issue 2, Pages (July 2014)
Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States  Ahmet Ergin, MD, PhD, MPH, Paul.
Symptom-based stratification of autoimmune diseases
Autism, maths, and sex: the special triangle
A disease of the osteoblast
Presentation transcript:

Serum neopterin in acute coronary syndromes S Gupta, S Fredericks, RA Schwartzman, DW Holt, JC Kaski  The Lancet  Volume 349, Issue 9060, Pages 1252-1253 (April 1997) DOI: 10.1016/S0140-6736(05)62447-6 Copyright © 1997 Elsevier Ltd Terms and Conditions

Figure Comparison of mean (SD) concentrations of neopterin/creatinine in patients with ischaemic heart disease and controls NC=control group; PMI=previous myocardial infarction; UA=unstable angina; AMI=acute myocardial infarction. Neopterin concentrations are expressed as neopterin/creatinine ratios corrected for renal function in all patients. Intra-assay and interassay variation of less than 5% and less than 12%, respectively, for neopterin. *UA vs PMI p<0·005. †UA vs NC p=0·02. ‡AMI vs NC and PMI p<0·001. The Lancet 1997 349, 1252-1253DOI: (10.1016/S0140-6736(05)62447-6) Copyright © 1997 Elsevier Ltd Terms and Conditions